Vlatka Perisa
Osijek, 31000, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
One Target, Different Results: The Clinical Impact of Diagnostic Kit Choice in BCR::ABL1 Testing for Chronic Myeloid Leukemia.
Journal: Diagnostics (Basel, Switzerland)
Published: June 15, 2026
From Sample to Sequencing: The Importance of Pre-Analytical Sample Treatment in NGS Analysis of Patients with Chronic Lymphocytic Leukemia.
Journal: Cancers
Published: October 21, 2025
Extreme Thrombocytosis in Patients with Overt Myelofibrosis and Its Clinical Associations.
Journal: Cancers
Published: March 12, 2025
Carfilzomib in relapsed/refractory multiple myeloma patients - real world evidence - experiences of the Croatian cooperative group for hematologic diseases (KROHEM).
Journal: Cancer treatment and research communications
Published: November 20, 2024
Outcomes of Ixazomib Treatment in Relapsed and Refractory Multiple Myeloma: Insights from Croatian Cooperative Group for Hematologic Diseases (KROHEM).
Journal: Medicina (Kaunas, Lithuania)
Published: September 21, 2024
The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients.
Journal: Biomedicines
Published: July 06, 2024
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.
Journal: Annals of hematology
Published: March 11, 2024
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.
Journal: Life (Basel, Switzerland)
Published: March 08, 2024
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.
Journal: Leukemia & lymphoma
Published: January 22, 2024
Last Updated: 09/26/2026